MedTrace Logo

A Study to Evaluate the Safety and Efficacy of MSENC1 Soft Hydrophilic Contact Lenses and Oxypure Color Soft Hydrophilic Contact Lenses

NCT06616519 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 192

Last updated 2024-09-27

No results posted yet for this study

Summary

This project is an open, parallel, randomly controlled, and non-inferiority clinical trial of MSENCI soft hydrophilic contact lenses with Oxypure color soft hydrophilic contact lenses used as the control product.

Conditions

  • Myopia

Interventions

DEVICE

BenQ Materials MSENCI soft hydrophilic contact lenses

Test lenses were to be worn for approximately 90 days.

DEVICE

Visco Oxypure Color soft hydrophilic contact lenses

Control lenses were to be worn for approximately 90 days

Sponsors & Collaborators

  • BenQ Materials Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-18
Primary Completion
2022-05-01
Completion
2022-08-25

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06616519 on ClinicalTrials.gov